45th Annual Securities Regulation Institute

• IP Litigation & Damages
• Articles

Biosimilars: Economic Issues for IP Litigation

In July 2021, the U.S. Food and Drug Administration granted a determination of interchangeability to a biosimilar drug for the first time. This approval has...

• Intellectual Property
• Speaking Engagement

• November 4-5, 2021
• Virtual

65th Annual Intellectual Property Law Conference

Anne Layne-Farrar is a panelist during the plenary session titled “Regulating IP and Technology.” For more information on this event, click here.